Ovarian cancer, version 1.2016: Clinical practice guidelines in oncology

Robert J. Morgan, Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum-Gamez, Kian Behbakht, Lee May Chen, Larry Copeland, Marta Ann Crispens, Maria De Rosa, Oliver Dorigo, David M. Gershenson, Heidi J. Gray, Ardeshir Hakam, Laura J. Havrilesky, Carolyn Johnston, Shashikant Lele, Lainie Martin, Ursula A. Matulonis, David M. O'Malley, Richard T. PensonSanja Percac-Lima, Mario Pineda, Steven C. Plaxe, Matthew A. Powell, Elena Ratner, Steven W. Remmenga, Peter G. Rose, Paul Sabbatini, Joseph T. Santoso, Theresa L. Werner, Jennifer Burns, Miranda Hughes

Research output: Contribution to journalArticlepeer-review

243 Scopus citations

Abstract

This selection from the NCCN Guidelines for Ovarian Cancer focuses on the less common ovarian histopathologies (LCOHs), because new algorithms were added for LCOHs and current algorithms were revised for the 2016 update. The new LCOHs algorithms include clear cell carcinomas, mucinous carcinomas, and grade 1 (low-grade) serous carcinomas/endometrioid epithelial carcinomas. The LCOHs also include carcinosarcomas (malignant mixed Müllerian tumors of the ovary), borderline epithelial tumors (also known as low malignant potential tumors), malignant sex cord-stromal tumors, and malignant germ cell tumors.

Original languageEnglish (US)
Pages (from-to)1134-1163
Number of pages30
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume14
Issue number9
DOIs
StatePublished - Sep 2016

Funding

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Ovarian cancer, version 1.2016: Clinical practice guidelines in oncology'. Together they form a unique fingerprint.

Cite this